SEC Form 4 · accession 0001209191-18-024455
Tracon Pharmaceuticals, Inc. · TCON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore T Wang
Director · 10% Owner
Period of report
Apr 6, 2018
Accepted (ET)
Apr 9, 2018 · 8:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001394319
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $2.55 | Apr 6, 2018 | A | 25,000 | A | — | Apr 5, 2028 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The shares subject to the option shall vest and become exercisable in three equal annual installments commencing on the first anniversary of the grant date set forth in column 3 above.